reports
Angelalign Technology Reports 2023 Interim Results: Strong Domestic Ca...
Angelalign Technology Reports 2023 Interim Results: Strong Domestic Case Growth While Investing in Global Expansion. Shanghai, China, Sept. 07, 2023 (GLOBE NEWSWIRE) -- In August, Angelalign Technology () reported 2023interim results, highlighting strong year-on-year growth in revenue (8%) and clear aligner case shipments (23.6%) while investing in commercial infrastructure as part of its global expansion. Mainland China: Clear aligner case shipments in China grew 11.4% year-on-year. General gross margin increased 130 bps year-on-year to 59.3%. The growth in Mainland China was driven by ...
Despite a better risk assessment and improving to Slightly Negative, A...
ANGELALIGN TECH (HK), a company active in the Medical Equipment industry, improves its market behaviour and slightly increases its general evaluation. The independent financial analyst theScreener just upgraded the stock market behaviour as moderately risky. At a fundamental level, theScreener confirms 1 out of 4 possible stars; the general evaluation is slightly increased to Slightly Negative but the title remains under pressure. As of the analysis date February 1, 2022, the closing price was H...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.